Øresund Pharma ApS
CVR 39492059 · Private limited company (ApS) · Active · Low risk
Øresund Pharma ApS is a Private limited company (ApS), founded on , based in Nordhavn. The company is registered in the industry engroshandel med medicinalvarer og sygeplejeartikler. Our model estimates a bankruptcy risk of 0.1% over the next 12 months, which is 0.0 times the average for Danish companies. 8 annual reports have been published. The latest annual report (31 Dec 2025) shows equity of DKK 44.6m and a net result of DKK 6.5m. CEO: Svend Aage Johansen.
Bankruptcy risk for Øresund Pharma ApS
0.0 × the average (1.41%) · higher risk than 27% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 39492059
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (8 years)
- Address
- Orient Plads 1
2150 Nordhavn - Municipality
- København
- Industry
- Engroshandel med medicinalvarer og sygeplejeartikler (464610)
Bankruptcies in the industry: Engroshandel med andre maskiner og andet udstyr - Share capital
- DKK 56k
- Employees
- 1 (2018)
- Auditor
- BDO Statsautoriseret Revisionspartnerselskab
- Audit opted out
- No
Warning signs
| Annual reports filed late | 0 of 8 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 35.0% |
| Current ratio | 121% |
| Moves (last 2 years) | 0 |
| CEO changes in total | 1 |
| CEO's previous bankruptcies | 0 |
| Other companies at the address | 38 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK 39.7m | DKK 39.6m | DKK 38.3m |
| Net profit | DKK 6.5m | DKK 13.7m | DKK 16.8m |
| Equity | DKK 44.6m | DKK 38.2m | DKK 24.4m |
| Total assets | DKK 127.6m | DKK 81.1m | DKK 42.5m |
| Cash | DKK 135k | DKK 557k | – |
| Short-term debt | DKK 82.8m | DKK 42.9m | – |
| Avg. employees | 16 | 11 | – |
Latest annual report: Reporting class B · auditor's statement: Den uafhængige revisors erklæring · BDO Statsautoriseret Revisionspartnerselskab.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 51 | ||
| 1 Jan 2024 – 31 Dec 2024 | 44 | ||
| 1 Jan 2023 – 31 Dec 2023 | 65 | ||
| 1 Jan 2022 – 31 Dec 2022 | 45 | ||
| 1 Jan 2021 – 31 Dec 2021 | 177 | ||
| 1 Jan 2020 – 31 Dec 2020 | 182 | ||
| 1 Jan 2019 – 31 Dec 2019 | 87 | ||
| 17 Apr 2018 – 31 Dec 2018 | 114 |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Svend Aage Johansen | Current | |
| Owner (90%) | Machpali ApS | Current | |
| Owner (10%) | ESH Holding 2019 ApS | Current | |
| Owner (100%) | Machpali ApS | ||
| Auditor | BDO Statsautoriseret Revisionspartnerselskab | Current | |
| Auditor | CHRISTENSEN KJÆRULFF STATSAUTORISERET REVISIONSAKTIESELSKAB | ||
| Auditor | BDO Holding VII, statsautoriseret revisionsaktieselskab | ||
| Founder | Machpali ApS | Current |
The CEOs' other companies
Svend Aage Johansen – 17 other companies
- ANESTIC ApS Compulsorily dissolved
- Atnahs Pharma Denmark ApS Active
- BECKETT INVEST ApS Compulsorily dissolved
- BIO RESEARCH A/S Opløst
- CCURE A/S Active
- CHR. OLESEN PHARMACEUTICALS A/S Active
- CHR. OLESEN SYNTHESIS A/S Active
- DLI - DANSK LÆGEMIDDEL INFORMATION A/S Active
- ETHNOCINE ApS Opløst
- INFORMEDICA A/S Compulsorily dissolved
- MEDIC TEAM A/S Fusioneret
- MEDICAL MATCH A/S Active
- MERCK A/S Opløst
- NM AF 18. JUNI 2009 A/S Active
- NORDMEDICA A/S Active
- Pharmanovia A/S Active
- TPR-GROUP ApS Active
Address history (2 moves)
| Orient Plads 1, 2150 Nordhavn | |
| Dronningens Tværgade 9, 3., 1302 København K | |
| Sundvænget 10, 2900 Hellerup |
Former names
| Øresund Pharma ApS | – now |
| Øresund Pharma IVS | – |
Employees per year
Other companies at the same address
- Abzu ApS Bankrupt
- MORTEN MØLLER HOLDING ApS Bankrupt
- SKAN VAGT ApS Bankrupt
- AHM AF 1997 HOLDING ApS Active
- AQUAROSA SHIPPING A/S Fusioneret
- ATLAS INVEST HOLDING A/S Opløst
- ATLAS X HOLDING A/S Opløst
- Aaen Engineering ApS Active
- Abzu Holding ApS Opløst
- Astora Consulting ApS Active
- Capax Holding ApS Fusioneret
- Clarity Partners Komplementarselskab ApS Active
- Copenhagen Assets I ApS Active
- Copenhagen Suites ApS Active
- DANCONTAINER A/S Active
- Dna Due Diligence Company ApS Active
- FALCON SHIP MANAGEMENT A/S Fusioneret
- FORMENTERA SHIPPING A/S Fusioneret
- G Meadow Holding ApS Active
- Genco Shipping A/S Active
- Green Meadow ApS Active
- Green Meadow Sales Nordic ApS Active
- JAMAC ApS Active
- MAC-INVEST ApS Active
- MEDICAL MATCH A/S Active
Similar companies in København
- ALFASCAN ApS København K
- LUNDBECK PHARMA A/S Valby
- ASTRAZENECA A/S København V
- Sundvik ApS Vanløse
- DEXCOM DENMARK, ApS København Ø
- Nitrilehandsker.dk ApS Valby
- DePuy Synthes (Denmark) ApS København K
- ELSE NORDICS APS København S
- MSD Animal Health A/S København V
- DentFriends ApS København S
- Sanad Health ApS København N
- Venteus Medical Devices (ROW) ApS København Ø
Questions and answers about Øresund Pharma ApS
Has Øresund Pharma ApS gone bankrupt?
No, Øresund Pharma ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Øresund Pharma ApS?
Our model estimates a bankruptcy risk of 0.1% over the next 12 months (low risk), which is 0.0 times the average for Danish companies.
Who is the CEO of Øresund Pharma ApS?
Svend Aage Johansen is the CEO of Øresund Pharma ApS.
Who is the auditor of Øresund Pharma ApS?
Øresund Pharma ApS most recently used BDO Statsautoriseret Revisionspartnerselskab.
When was Øresund Pharma ApS founded?
Øresund Pharma ApS was founded on 17 April 2018.
What is the equity of Øresund Pharma ApS?
Equity was DKK 44.6m according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.